These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32383980)

  • 21. Integrated Analysis of Multiomics Data Identified Molecular Subtypes and Oxidative Stress-Related Prognostic Biomarkers in Glioblastoma Multiforme.
    Ma Y; Xi Z
    Oxid Med Cell Longev; 2022; 2022():9993319. PubMed ID: 36193073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrative multi-omics characterization reveals sex differences in glioblastoma.
    Jang B; Yoon D; Lee JY; Kim J; Hong J; Koo H; Sa JK
    Biol Sex Differ; 2024 Mar; 15(1):23. PubMed ID: 38491408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Automated network analysis identifies core pathways in glioblastoma.
    Cerami E; Demir E; Schultz N; Taylor BS; Sander C
    PLoS One; 2010 Feb; 5(2):e8918. PubMed ID: 20169195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
    Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
    BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI to MGMT: predicting methylation status in glioblastoma patients using convolutional recurrent neural networks.
    Han L; Kamdar MR
    Pac Symp Biocomput; 2018; 23():331-342. PubMed ID: 29218894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
    Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
    Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
    [No Abstract]   [Full Text] [Related]  

  • 28. Software for the Integration of Multiomics Experiments in Bioconductor.
    Ramos M; Schiffer L; Re A; Azhar R; Basunia A; Rodriguez C; Chan T; Chapman P; Davis SR; Gomez-Cabrero D; Culhane AC; Haibe-Kains B; Hansen KD; Kodali H; Louis MS; Mer AS; Riester M; Morgan M; Carey V; Waldron L
    Cancer Res; 2017 Nov; 77(21):e39-e42. PubMed ID: 29092936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visualizing molecular profiles of glioblastoma with GBM-BioDP.
    Celiku O; Johnson S; Zhao S; Camphausen K; Shankavaram U
    PLoS One; 2014; 9(7):e101239. PubMed ID: 25010047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-omics analysis predicts fibronectin 1 as a prognostic biomarker in glioblastoma multiforme.
    Kabir F; Apu MNH
    Genomics; 2022 May; 114(3):110378. PubMed ID: 35513291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Molecular Voyage: Multiomics Insights into Circulating Tumor Cells.
    Zhang YW; Gvozdenovic A; Aceto N
    Cancer Discov; 2024 Jun; 14(6):920-933. PubMed ID: 38581442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and Validation of a MRI-Based Radiomics Prognostic Classifier in Patients with Primary Glioblastoma Multiforme.
    Chen X; Fang M; Dong D; Liu L; Xu X; Wei X; Jiang X; Qin L; Liu Z
    Acad Radiol; 2019 Oct; 26(10):1292-1300. PubMed ID: 30660472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling.
    Zheng S; Wu Y; Li Z
    Radiother Oncol; 2021 Jan; 154():36-44. PubMed ID: 32918970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiview learning for understanding functional multiomics.
    Nguyen ND; Wang D
    PLoS Comput Biol; 2020 Apr; 16(4):e1007677. PubMed ID: 32240163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-operative MRI radiomics model non-invasively predicts key genomic markers and survival in glioblastoma patients.
    Pease M; Gersey ZC; Ak M; Elakkad A; Kotrotsou A; Zenkin S; Elshafeey N; Mamindla P; Kumar VA; Kumar AJ; Colen RR; Zinn PO
    J Neurooncol; 2022 Oct; 160(1):253-263. PubMed ID: 36239836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive analysis of the angiogenesis-related genes in glioblastoma multiforme vs. brain lower grade glioma.
    Biterge-Sut B
    Arq Neuropsiquiatr; 2020 Jan; 78(1):34-38. PubMed ID: 32074192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
    Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
    CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme.
    Wang K; Lu Y; Liu Z; Diao M; Yang L
    Biomed Res Int; 2022; 2022():7858477. PubMed ID: 35155681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiogenomic mapping of edema/cellular invasion MRI-phenotypes in glioblastoma multiforme.
    Zinn PO; Mahajan B; Sathyan P; Singh SK; Majumder S; Jolesz FA; Colen RR
    PLoS One; 2011; 6(10):e25451. PubMed ID: 21998659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of biomarkers for pseudo and true progression of GBM based on radiogenomics study.
    Qian X; Tan H; Zhang J; Liu K; Yang T; Wang M; Debinskie W; Zhao W; Chan MD; Zhou X
    Oncotarget; 2016 Aug; 7(34):55377-55394. PubMed ID: 27421136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.